Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders

Psychiatry Research

Volumn 185, Issue 1-2, 2011, Pages 205-210

  Pérez de los Cobos, José ^a   Siñol, Núria ^a   Puerta, Carmen ^b   Cantillano, Vanessa ^a,c   López Zurita, Cristina ^b   Trujols, Joan ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Instituto de Adicciones   (Spain)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Abuse; ADHD; Comorbidity; Dependence; Psychostimulants

Indexed keywords

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL FEATURE; COCAINE DEPENDENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; SPAIN;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHI-SQUARE DISTRIBUTION; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SPAIN; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 78650198446     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.03.019     Document Type: Article

References (44)

1. Alterman A.I., Kampman K., Boardman C.R., Cacciola J.S., Rutherford M.J., McKay J.R., Maany I. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug and Alcohol Dependence 1997, 46:79-85.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, D.C, (DSM-IV). fourth ed.
3. Baldessarini R.J., Finklestein S., Arana G.W. The predictive power of diagnostic tests and the effect of prevalence of illness. Archives of General Psychiatry 1983, 40:569-573.
4. Biederman J., Wilens T., Mick E., Milberger S., Spencer T.J., Faraone S.V. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry 1995, 152:1652-1658.
5. Biederman J., Wilens T., Mick E., Faraone S.V., Weber W., Curtis S., Thornell A., Pfister K., Jetton J.G., Soriano J. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36:21-29.
6. Biederman J., Monuteaux M.C., Mick E., Wilens T.E., Fontanella J.A., Poetzl K.M., Kirk T., Masse J., Faraone S.V. Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder. Biological Psychiatry 2006, 59:258-264.
7. Carroll K.M., Rounsaville B.J. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry 1993, 34:75-82.
8. Doran N., Spring B., McChargue D. Effect of impulsivity on craving and behavioral reactivity to smoking cues. Psychopharmacology 2007, 194:279-288.
9. Ehrman R.N., Robbins S.J., Cornish J.W. Results of a baseline urine test predict levels of cocaine use during treatment. Drug and Alcohol Dependence 2001, 62:1-7.
10. Elkins I.J., McGue M., Iacono W.G. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Archives of General of Psychiatry 2007, 64:1145-1152.
11. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Annual report: the state of the drugs problem in Europe. Office for Official Publications of the European Communities, Luxembourg 2007.
12. Faraone S.V., Biederman J., Spencer T., Mick E., Murray K., Petty C., Adamson J.J., Monuteaux M.C. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?. American Journal of Psychiatry 2006, 163:1720-1729.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Entrevista clínica estructurada para los trastornos del eje I del DSM-IV (SCID-I), vesión clínica. Structured clinical interview for DSM-IV axis I disorders, clinician version 1999, Masson, Barcelona.
14. Flory K., Lynam D.R. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play?. Clinical Child and Family Psychology Review 2003, 6:1-16.
15. Ghitza U.E., Epstein D.H., Preston K.L. Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-test method. Drug and Alcohol Dependence 2007, 91:169-177.
16. Johnston C., Mash E.J. Families and children with attention-deficit/hyperactivity disorder: review and recommendations for future research. Clinical Child and Family Psychology Review 2001, 4:183-207.
17. Kampman K.M., Volpicelli J.R., Mulvaney F., Rukstalis M., Alterman A.I., Pettinati H., Weinreib R.M., O'Brien C.P. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive Behaviors 2002, 27:251-260.
18. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., Faraone S.V., Greenhill L.L., Howes M.J., Secnik K., Spencer T., Ustun T.B., Walters E.E., Zaslavsky A.M. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry 2006, 163:716-723.
19. Kollins S.H., McClernon J.M., Fuemmeler B.F. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Archives of General Psychiatry 2005, 62:1142-1147.
20. Lambert N.M., Hartsough C.S. Prospective study of tobacco smoking and substance dependence among samples of ADHD and non-ADHD participants. Journal of Learning Disabilities 1998, 31:533-544.
21. Levin F.R. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. Journal of Clinical Psychiatry 2007, 68(suppl 11):9-14.
22. Levin F.R., Evans S.M., Kleber H.D. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence 1998, 52:15-25.
23. Levin F.R., Evans S.M., Brooks D.J., Garawi F. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug and Alcohol Dependence 2007, 87:20-29.
24. Manuzza S., Klein R.G., Klein D.F., Bessler A., Shrout P. Accuracy of adult recall of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry 2002, 159:1882-1888.
25. McCann B.S., Scheele L., Ward N., Roy-Byrne P. Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. Journal of Neuropsychiatry and Clinical Neuroscience 2000, 12:240-245.
26. Milberger S., Biederman J., Faraone S.V., Chen L., Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36:37-44.
27. Moeller F.G., Dougherty D.M., Barratt E.S., Schmitz J.M., Swann A.C., Grabowski J. The impact of impulsivity on cocaine use and retention in treatment. Journal of Substance and Abuse Treatment 2001, 21:193-198.
28. Murphy P., Schachar R. Use of self-rating in the assessment of symptoms of attention deficit hyperactivity disorder in adults. American Journal of Psychiatry 2000, 7:1156-1159.
29. Oquendo M.A., Baca-Garcia E., Graver R., Morales M., Moltalvan V., Mann J.J. Spanish adaptation of the Barratt impulsiveness scale (BIS-11). European Journal of Psychiatry 2001, 15:147-155.
30. Patkar A.A., Thornton C.C., Berrettini W.H., Gottheil E., Weinstein S.P., Hill K.P. Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures. Journal of Substance and Abuse Treatment 2002, 23:33-40.
31. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology 1995, 51:768-774.
32. Pérez de los Cobos J., López-Ibor J.J., Sopelana P., Castañeda M. Cocaine use and opioid withdrawal syndrome. European Psychiatry 1991, 6:89-92.
33. Pérez de los Cobos J., Trujols J., Ribalta E., Casas M. Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice. American Journal of Drug and Alcohol Abuse 1997, 23:267-279.
34. Polanczyk G., Rohde L.A. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Current Opinion in Psychiatry 2007, 20:386-392.
35. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 2007, 164:942-948.
36. Rey J.M., Sawyer M.G. Are psychostimulant drugs being used appropriately to treat child and adolescent disorders?. British Journal of Psychiatry 2003, 182:284-286.
37. Rodríguez-Jiménez R., Ponce G., Monasor R., Jiménez-Giménez M., Pérez-Rojo J.A., Rubio G., Jiménez-Arriero M.A., Palomo T. Validación en población española adulta de la Wender-Utah Rating Scale para la evaluación retrospectiva de trastornos por déficit de atención e hiperactividad en la infancia (Validation in the Spanish population of the Wender-Utah rating scale for the retrospective evaluation in adults of attention deficit/hyperactivity disorder in early ages). Revista de Neurología 2001, 33:138-144.
38. Ros A., Valoria A., Nieto J. Consumo de cocaína y otros psicoestimulantes: su relación con el síndrome de hiperactividad infantil (Cocaine and other psychostimulant consumption: their relationship with childhood hyperactivity syndrome). Actas Españolas de Psiquiatría 2004, 32:346-352.
39. Schubiner H., Saules K.K., Arfken C.L., Johanson C.E., Schuster C.R., Lockhart N., Edwards A., Donlin J., Pihlgren E. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology 2002, 10:286-294.
40. Ward M.F., Wender P.H., Reimherr F.W. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry 1993, 150:885-890.
41. Weiss R.D., Mirin S.M., Griffin M.L., Michael J.L. Psychopathology in cocaine abusers. Changing trends. Journal of Nervous and Mental Disease 1988, 176:719-725.
42. Wilens T.E., Biederman J., Mick E., Faraone S.V., Spencer T. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. Journal of Nervous and Mental Disease 1997, 185:475-482.
43. Wilens T.E., Faraone S.V., Biederman J., Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111:179-185.
44. Zilberman M.L., Tavares H., Hodgins D.C., el-Guebaly N. The impact of gender, depression, and personality on craving. Journal of Addictive Diseases 2007, 26:79-84.